3 years ago

Identification of chlamydial T3SS inhibitors through virtual screening against T3SS ATPase

Identification of chlamydial T3SS inhibitors through virtual screening against T3SS ATPase
L. N Kapotina, S. I Luyksaar, E. S Zayakin, N A Zigangirova, A. S Karyagina, D. D Kirsanov, A. V Grishin
Chlamydia trachomatis is a widespread sexually transmitted pathogen that resides within a special vacuole inside host cells. Although acute infection can be treated with antibiotics, chlamydia can enter persistent state, leading to chronic infection that is difficult to cure. Thus, novel anti-chlamydial compounds active against persistent chlamydia are required. Chlamydia rely upon type III secretion system (T3SS) to inject effector proteins into host cell cytoplasm, and T3SS inhibitor are viewed as promising compounds for treatment of chlamydial infections. C. trachomatis ATPase SctN is an important T3SS component and has not been targeted before. We thus used virtual screening against homology modelled SctN structure to search for SctN inhibitors. Selected compounds were tested for their ability to inhibit chlamydial survival and development within eukaryotic cells, and for the ability to suppress normal T3SS functioning. We identified 2 compounds that were able to block normal protein translocation through T3SS and inhibit chlamydial survival within eukaryotic cells in 50-100 μM concentrations. These two novel T3SS inhibitors also possessed relatively low toxicity towards eukaryotic cells. A small series of derivatives was further synthesized for the most active of two inhibitors to probe SAR properties. This article is protected by copyright. All rights reserved. Virtual screening was performed against a homology model of Chlamydia trachomatis type III secretion system (T3SS) ATPase. As a result, a series of N-arylbenzylamines was identified as compounds that were able to inhibit effector protein export by C. trachomatis T3SS and suppress chlamydial development inside eukaryotic cells.

Publisher URL: http://onlinelibrary.wiley.com/resolve/doi

DOI: 10.1111/cbdd.13130

You might also like
Discover & Discuss Important Research

Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery and making important discussions happen. With over 19,000 sources, including peer-reviewed journals, preprints, blogs, universities, podcasts and Live events across 10 research areas, you'll never miss what's important to you. It's like social media, but better. Oh, and we should mention - it's free.

  • Download from Google Play
  • Download from App Store
  • Download from AppInChina

Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.